Search form

Search

Navigation

home
boards
job center
job ratings
cp wire
device news
trending now
- trending in pharma/biotech
- trending in device
pharmagather
advertise
contact us

You are here

Home » 3 Things Exelixis Must Do to Survive and Thrive in 2017

3 Things Exelixis Must Do to Survive and Thrive in 2017

3 Things Exelixis Must Do to Survive and Thrive in 2017

Motley Fool

news tags

Abbott Laboratories AbbVie Allergan Amgen Arena Pharmaceuticals AstraZeneca Biogen Idec biotech Bristol-Myers Squibb cancer Celgene China clinical trials devices diabetes drug pricing earnings Eli Lilly Europe FDA generics Gilead Sciences GSK hepatitis C JNJ layoffs M&A Medtronic Merck Novartis obesity patents Pfizer Pharma CEOs R&D Roche Sanofi Teva Pharmaceuticals vaccines Valeant Pharmaceuticals

privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter | social media-pharma | social media-med device | cafebanking

Copyright © 2017,